PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.

Autor: Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Jackson ER; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Parackal SG; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Kiltschewskij D; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Mannan A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Staudt DE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Thomas BC; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Germon ZP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Laternser S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland., Kearney PS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Jamaluddin MFB; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Douglas AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Beitaki T; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., McEwen HP; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Persson ML; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia., Hocke EA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Jain V; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Aksu M; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA., Manning EE; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Murray HC; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Verrills NM; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Sun CX; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Daniel P; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Vilain RE; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Skerrett-Byrne DA; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Nixon B; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Hua S; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., de Bock CE; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Colino-Sanguino Y; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Valdes-Mora F; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Tsoli M; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia., Ziegler DS; Children's Cancer Institute, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.; School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia., Cairns MJ; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Raabe EH; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Vitanza NA; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA., Hulleman E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Koschmann C; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Alvaro F; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia., Dayas CV; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia., Tinkle CL; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Wheeler H; Department of Radiation Oncology Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; The Brain Cancer group, St Leonards, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, Australia., Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia., Eisenstat DD; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.; Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Firestein R; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Mueller S; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Department of Neurology, Neurosurgery, and Pediatrics, University of California, San Francisco, California, USA., Valvi S; Department of Paediatric and Adolescent Oncology/Haematology, Perth Children's Hospital, Nedlands, Washington, Australia.; Brain Tumour Research Laboratory, Telethon Kids Institute, Nedlands, Washington, Australia.; Division of Paediatrics, University of Western Australia Medical School, Nedlands, Western Australia, Australia., Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, North Adelaide, South Australia, Australia.; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.; South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., Ashley DM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Gregory SG; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Kilburn LB; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA., Nazarian J; DIPG/DMG Research Center Zurich, Children's Research Center, Department of Pediatrics, University Children's Hospital Zürich, Zurich, Switzerland.; Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.; The George Washington University, School of Medicine and Health Sciences, Washington, DC, USA., Cain JE; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Dun MD; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Paediatric Stream, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, New South Wales, Australia.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Feb 06; Vol. 134 (6). Date of Electronic Publication: 2024 Feb 06.

ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.

Autor: Jackson ER; The University of Newcastle, Callaghan, NSW, Australia., Duchatel RJ; The University of Newcastle, Callaghan, NSW, Australia., Staudt DE; The University of Newcastle, Callaghan, NSW, Australia., Persson ML; The University of Newcastle, Callaghan, NSW, Australia., Mannan A; The University of Newcastle, Callaghan, NSW, Australia., Yadavilli S; Children's National Hospital, Washington, DC, United States., Parackal S; Hudson Institute of Medical Research, Clayton, VIC, Australia., Game S; Hudson Institute of Medical Research, Clayton, VIC, Australia., Chong WC; Hudson Institute of Medical Research, Clayton, VIC, Australia., Jayasekara WSN; Hudson Institute of Medical Research, Clayton, Victoria, Australia., Le Grand M; Cancer Research Center of Marseille, Marseille CEDEX 09, France., Kearney PS; The University of Newcastle, Callaghan, NSW, Australia., Douglas AM; The University of Newcastle, Callaghan, NSW, Australia., Findlay IJ; The University of Newcastle, Callaghan, NSW, Australia., Germon ZP; The University of Newcastle, Callaghan, NSW, Australia., McEwen HP; The University of Newcastle, Callaghan, NSW, Australia., Beitaki TS; The University of Newcastle, Callaghan, NSW, Australia., Patabendige A; Edge Hill University, Ormskirk, United Kingdom., Skerrett-Byrne DA; The University of Newcastle, Callaghan, NSW, Australia., Nixon B; The University of Newcastle, Callaghan, NSW, Australia., Smith ND; The University of Newcastle, Callaghan, NSW, Australia., Day B; QIMR Berghofer MRI, Brisbane, Queensland, Australia., Manoharan N; Sydney Children's Hospital, Randwick, NSW, Australia., Nagabushan S; Sydney Children's Hospital, Randwick, New South Wales, Australia., Hansford JR; Women's and Children's Hospital, North Adelaide, SA, Australia., Govender D; The Children's Hospital at Westmead, Westmead, NSW, Australia., McCowage GB; Children's Hospital at Westmead, Sydney, Australia., Firestein R; Genentech Inc, S. San Francisco, United States., Howlett M; University of Western Australia, Perth, WA, Australia., Endersby R; Telethon Kids Institute, Nedlands, Western Australia, Australia., Gottardo NG; Telethon Kids Institute, Perth, Western Australia, Australia., Alvaro F; John Hunter Children's Hospital, New Lambton Heights, NSW, Australia., Waszak SM; University of Oslo, Oslo, Norway., Larsen MR; University of Southern Denmark, Odense M, Denmark., Colino-Sanguino Y; Children's Cancer Institute, Sydney, NSW, Australia., Valdés-Mora F; Children's Cancer Institute, Sydney, Australia., Rakotomalala A; Univ. Lille, CNRS, Inserm, CHU Lille, Centre Oscar Lambret, Lille, France., Meignan S; Centre Oscar Lambret, LILLE, France., Pasquier E; Cancer Research Center of Marseille, Marseille CEDEX 09, France., Andre N; AP-HM, Aix Marseille Université, Marseille, France., Hulleman E; VU University Medical Center-Cancer Centrer Amsterdam, Amsterdam, Netherlands., Eisenstat DD; The Royal Children's Hospital and University of Melbourne, Melbourne, Victoria, Australia., Vitanza NA; Seattle Children's Research Institute, Seattle, WA, United States., Nazarian J; Children's National Medical Center, Washington, United States., Koschmann C; University of Michigan-Ann Arbor, Ann Arbor, MI, United States., Mueller S; University of California, San Francisco, San Francisco, CA, United States., Cain JE; Hudson Institute of Medical Research, Clayton, Victoria, Australia., Dun MD; The University of Newcastle, Callaghan, NSW, Australia.

Publikováno v: Cancer research [Cancer Res] 2023 May 05. Date of Electronic Publication: 2023 May 05.

Early microglial response, myelin deterioration and lethality in mice deficient for very long chain ceramide synthesis in oligodendrocytes.

Autor: Teo JD; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Marian OC; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Spiteri AG; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Nicholson M; Department of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia., Song H; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Khor JXY; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., McEwen HP; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Ge A; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Sen MK; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Piccio L; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia.; Department of Neurology, Washington University School of Medicine, St Louis, Missouri, USA., Fletcher JL; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania, Australia., King NJC; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia., Murray SS; Department of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia., Brüning JC; Max Planck Institute for Metabolism Research, Cologne, Germany., Don AS; Charles Perkins Centre and School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia.

Publikováno v: Glia [Glia] 2023 Apr; Vol. 71 (4), pp. 1120-1141. Date of Electronic Publication: 2022 Dec 30.

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection.

Autor: Staudt DE; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Murray HC; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Skerrett-Byrne DA; School of Environmental and Life Sciences, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW, 2308, Australia.; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Smith ND; Analytical and Biomolecular Research Facility (ABRF), Research Services, University of Newcastle, NSW, Callaghan, 2308, Australia., Jamaluddin MFB; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia., Kahl RGS; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia., Duchatel RJ; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Germon ZP; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., McLachlan T; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Jackson ER; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Findlay IJ; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Kearney PS; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Mannan A; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., McEwen HP; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Douglas AM; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia., Nixon B; School of Environmental and Life Sciences, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW, 2308, Australia.; Infertility and Reproduction Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Verrills NM; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia., Dun MD; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia. matt.dun@newcastle.edu.au.; Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, 2305, Australia. matt.dun@newcastle.edu.au.

Publikováno v: Clinical proteomics [Clin Proteomics] 2022 Dec 19; Vol. 19 (1), pp. 48. Date of Electronic Publication: 2022 Dec 19.

Lipidome changes in alcohol-related brain damage.

Autor: Smith CC; Faculty of Medicine and Health, School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Sheedy DL; Faculty of Medicine and Health, School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., McEwen HP; Centenery Institute, The University of Sydney, Sydney, New South Wales, Australia., Don AS; Faculty of Medicine and Health, School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Centenery Institute, The University of Sydney, Sydney, New South Wales, Australia., Kril JJ; Faculty of Medicine and Health, School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Sutherland GT; Faculty of Medicine and Health, School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Publikováno v: Journal of neurochemistry [J Neurochem] 2022 Jan; Vol. 160 (2), pp. 271-282. Date of Electronic Publication: 2021 Nov 11.